UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
876
DELISTED
Blueprint Medicines
BPMC
| $11.4M | 0.01% |
252,349
-9,336
| -4% | -$421K |
|
|
KW
877
DELISTED
Kennedy-Wilson Holdings
KW
| $11.3M | 0.01% |
683,858
-89,561
| -12% | -$1.53M |
|
878
First American
FAF
$7.58B
| $11.3M | 0.01% |
202,707
-5,964
| -3% | -$342K |
|
|
MRTX
879
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.3M | 0.01% |
302,821
+62,919
| +26% | +$2.83M |
|
880
DigitalOcean
DOCN
$14.6B
| $11.3M | 0.01% |
287,305
-3,163
| -1% | -$99.5K |
|
881
Flowers Foods
FLO
$1.57B
| $11.3M | 0.01% |
410,531
+297
| +0.1% | +$8.19K |
|
882
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.42B
| $11.2M | 0.01% |
789,473
+270,152
| +52% | +$3.88M |
|
883
NOV
NOV
$7B
| $11.2M | 0.01% |
605,428
+18,785
| +3% | +$406K |
|
|
SILK
884
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $11.2M | 0.01% |
286,224
-9,025
| -3% | -$441K |
|
885
Treace Medical Concepts
TMCI
$309M
| $11.1M | 0.01% |
442,353
+425,296
| +2,493% | +$9.99M |
|
|
ITCI
886
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.1M | 0.01% |
205,312
+4,599
| +2% | +$222K |
|
887
Envista
NVST
$4.52B
| $11.1M | 0.01% |
271,887
+9,172
| +3% | +$349K |
|
|
XIFR
888
XPLR Infrastructure LP
XIFR
$1.08B
| $11.1M | 0.01% |
182,092
+73,245
| +67% | +$5.04M |
|
889
Autohome
ATHM
$2.62B
| $11M | 0.01% |
330,074
-503
| -0.2% | -$16.9K |
|
890
Futu Holdings
FUTU
$15.3B
| $11M | 0.01% |
212,390
+4,761
| +2% | +$231K |
|
891
Hawaiian Electric Industries
HE
$2.14B
| $11M | 0.01% |
285,679
+2,285
| +0.8% | +$92.6K |
|
892
Prothena Corp
PRTA
$450M
| $11M | 0.01% |
226,202
-2,166
| -0.9% | -$114K |
|
893
New York Times
NYT
$10.2B
| $10.9M | 0.01% |
281,347
+5,286
| +2% | +$195K |
|
894
Littelfuse
LFUS
$11.6B
| $10.9M | 0.01% |
40,777
-920
| -2% | -$236K |
|
895
Zions Bancorporation
ZION
$10.3B
| $10.9M | 0.01% |
364,774
+17,950
| +5% | +$821K |
|
896
Compañía de Minas Buenaventura
BVN
$8.67B
| $10.9M | 0.01% |
1,333,186
+11,297
| +0.9% | +$90.1K |
|
897
Exelixis
EXEL
$13.4B
| $10.9M | 0.01% |
560,684
+9,569
| +2% | +$167K |
|
898
AutoNation
AN
$6.92B
| $10.8M | 0.01% |
80,663
-7,409
| -8% | -$951K |
|
|
PWSC
899
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $10.8M | 0.01% |
545,734
+476,191
| +685% | +$10.4M |
|
|
X
900
DELISTED
US Steel
X
| $10.8M | 0.01% |
414,347
-11,751
| -3% | -$326K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.